Improved chemotherapy modeling with RAG-based immune deficient mice

We have previously characterized an acute myeloid leukemia (AML) chemotherapy model for SCID-based immune deficient mice (NSG and NSGS), consisting of 5 days of cytarabine (AraC) and 3 days of anthracycline (doxorubicin), to simulate the standard 7+3 chemotherapy regimen many AML patients receive. W...

Descripción completa

Detalles Bibliográficos
Autores principales: Wunderlich, Mark, Manning, Nicole, Sexton, Christina, Sabulski, Anthony, Byerly, Luke, O’Brien, Eric, Perentesis, John P., Mizukawa, Benjamin, Mulloy, James C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6867639/
https://www.ncbi.nlm.nih.gov/pubmed/31747424
http://dx.doi.org/10.1371/journal.pone.0225532

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6867639/
https://www.ncbi.nlm.nih.gov/pubmed/31747424
http://dx.doi.org/10.1371/journal.pone.0225532

Ejemplares similares